Literature DB >> 10667966

Psychotic episodes during zonisamide treatment.

T Miyamoto1, M Kohsaka, T Koyama.   

Abstract

Several articles have appeared over the last years devoted to mental side effects during zonisamide (ZNS) treatment. In this study, we were particularly interested in psychotic episodes. Seventy-four epileptic patients with a history of ZNS treatment were surveyed retrospectively over the period spanning 1 March 1984 to 30 June 1994. They were divided into two groups according to the presence or absence of psychotic episodes during ZNS treatment. We analysed various factors pertaining to psychotic episodes during ZNS treatment. Of the 74 patients 14 had psychotic episodes. We found that the incidence of psychotic episodes during ZNS treatment was several times higher than the previously reported prevalence of epileptic psychosis, and that the risk of psychotic episodes was higher in young patients. In 13 patients, psychotic episodes occurred within a few years of commencement of ZNS. In children, obsessive-compulsive symptoms appeared to be related to psychotic episodes. It is important to terminate ZNS as soon as possible if psychotic episodes develop and never restart, even if seizures become worse. It cannot definitely be proved that ZNS causes psychotic episodes, as information on mental side effects during ZNS monotherapy is scant, but it does appear likely that ZNS contributes to psychotic episodes during polytherapy. Copyright 2000 BEA Trading Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10667966     DOI: 10.1053/seiz.1999.0368

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  7 in total

Review 1.  Suicidality and antiepileptic drugs: is there a link?

Authors:  Vladimir V Kalinin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 2.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 3.  Comparative efficacy and tolerability of drug treatments for bipolar disorder.

Authors:  S M Strakowski; M P DelBello; C M Adler
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study.

Authors:  J R White; T S Walczak; S E Marino; T E Beniak; I E Leppik; A K Birnbaum
Journal:  Neurology       Date:  2010-08-10       Impact factor: 9.910

5.  Zonisamide-Induced Hallucinations: An Anticonvulsant's Psychosis.

Authors:  Abdul Rahman Al Armashi; Patil Balozian; Francisco J Somoza-Cano; Kanchi Patell; Keyvan Ravakhah
Journal:  Cureus       Date:  2021-07-15

Review 6.  Use of second-generation antiepileptic drugs in the pediatric population.

Authors:  Allison M Chung; Lea S Eiland
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 7.  Behavioural effects of the new anticonvulsants.

Authors:  F M Besag
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.